Protective Effects of Lithium on Acetic Acid-Induced Colitis in Rats

[1]  Steven J Brown,et al.  The Immune Response in Inflammatory Bowel Disease , 2007, The American Journal of Gastroenterology.

[2]  F. Da Settimo,et al.  Inhibition of Adenosine Deaminase Attenuates Inflammation in Experimental Colitis , 2007, Journal of Pharmacology and Experimental Therapeutics.

[3]  J. González‐Gallego,et al.  Glutamine inhibits over-expression of pro-inflammatory genes and down-regulates the nuclear factor kappaB pathway in an experimental model of colitis in the rat. , 2007, Toxicology.

[4]  J. González‐Gallego,et al.  The anti-inflammatory flavones quercetin and kaempferol cause inhibition of inducible nitric oxide synthase, cyclooxygenase-2 and reactive C-protein, and down-regulation of the nuclear factor kappaB pathway in Chang Liver cells. , 2007, European journal of pharmacology.

[5]  H. Hagar,et al.  Ameliorative effect of pyrrolidinedithiocarbamate on acetic acid-induced colitis in rats. , 2007, European journal of pharmacology.

[6]  K. Krause,et al.  Expression of NOX1, a superoxide‐generating NADPH oxidase, in colon cancer and inflammatory bowel disease , 2005, The Journal of pathology.

[7]  G. Rogler.  Update in inflammatory bowel disease pathogenesis , 2004, Current opinion in gastroenterology.

[8]  H. Verspaget,et al.  Intestinal oxidative damage in inflammatory bowel disease: semi‐quantification, localization, and association with mucosal antioxidants , 2003, The Journal of pathology.

[9]  R. Cross,et al.  Nitric Oxide in Inflammatory Bowel Disease , 2003, Inflammatory bowel diseases.

[10]  David A. Brenner,et al.  Role of glycogen synthase kinase-3 in TNF-α-induced NF-κB activation and apoptosis in hepatocytes , 2002 .

[11]  D. Granger,et al.  Regulation of Murine Intestinal Inflammation by Reactive Metabolites of Oxygen and Nitrogen , 2001, The Journal of experimental medicine.

[12]  H. Manji,et al.  The effects of lithium on ex vivo cytokine production , 2001, Biological Psychiatry.

[13]  Y. Ikada,et al.  An oral drug delivery system targeting immune-regulating cells ameliorates mucosal injury in trinitrobenzene sulfonic acid-induced colitis. , 2001, The Journal of pharmacology and experimental therapeutics.

[14]  J. Becker,et al.  NK-1 antagonist reduces colonic inflammation and oxidative stress in dextran sulfate-induced colitis in rats. , 2000, American journal of physiology. Gastrointestinal and liver physiology.

[15]  S. Stryker,et al.  Total Antioxidant Capacity of Colon in Patients with Chronic Ulcerative Colitis , 2000, Digestive Diseases and Sciences.

[16]  A. Dehpour,et al.  Comparison of simultaneous administration of lithium with L‐NAME or L‐arginine on morphine withdrawal syndrome in mice , 2000, Human psychopharmacology.

[17]  Shu-xian Wang,et al.  A chronic ulcerative colitis model in rats. , 2000, World journal of gastroenterology.

[18]  R. Lorenz,et al.  Cyclooxygenase-2-dependent arachidonic acid metabolites are essential modulators of the intestinal immune response to dietary antigen , 1999, Nature Medicine.

[19]  J. Mcghee,et al.  Hapten-induced Colitis Is Associated with Colonic Patch Hypertrophy and T Helper Cell 2–Type Responses , 1999, The Journal of experimental medicine.

[20]  M. Sans,et al.  Effects of steroid treatment on activation of nuclear factor κB in patients with inflammatory bowel disease , 1998, British journal of pharmacology.

[21]  M. Balk,et al.  The Role of Reactive Oxygen Metabolites in Ulcerative Colitis , 1997, Inflammatory bowel diseases.

[22]  P. Barnes,et al.  Nuclear factor-κB , 1997 .

[23]  C. Elson,et al.  The basis of current and future therapy for inflammatory bowel disease. , 1996, The American journal of medicine.

[24]  J. Wallace,et al.  Reactivation of hapten-induced colitis and its prevention by anti-inflammatory drugs. , 1995, The American journal of physiology.

[25]  D. Hart,et al.  Lithium chloride enhances survival of NZB/W lupus mice: influence of melatonin and timing of treatment. , 1995, International journal of immunopharmacology.

[26]  B. Ramakrishna,et al.  Colonic mucosal antioxidant enzymes and lipid peroxide levels in normal subjects and patients with ulcerative colitis , 1995, Journal of gastroenterology and hepatology.

[27]  V. Gallicchio,et al.  Effect of lithium in immunodeficiency: improved blood cell formation in mice with decreased hematopoiesis as the result of LP-BM5 MuLV infection. , 1995, Antiviral research.

[28]  J. Taljaard,et al.  Evidence that lithium induces a glutamatergic: Nitric oxide-mediated response in rat brain , 1994, Neurochemical Research.

[29]  R. Macdermott,et al.  Enhand secretion of tumour necrosis factor‐alpha, IL‐6, and IL‐1β by isolated lamina ropria monouclear cells from patients with ulcretive cilitis and Crohn's disease , 1993 .

[30]  J. Wallace,et al.  Hapten-induced model of chronic inflammation and ulceration in the rat colon. , 1989, Gastroenterology.

[31]  A. Bendich,et al.  Free radical tissue damage: protective role of antioxidant nutrients 1 , 1987, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[32]  J. Lieb.  Lithium and immune function. , 1987, Medical hypotheses.

[33]  IN Teens,et al.  MANIC-DEPRESSIVE ILLNESS , 1986, The Lancet.

[34]  K. Mullane,et al.  Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemic myocardium. , 1985, Journal of pharmacological methods.

[35]  R. Ebstein,et al.  The effect of lithium on noradrenaline-induced cyclic AMP accumulation in rat brain: inhibition after chronic treatment and absence of supersensitivity. , 1980, The Journal of pharmacology and experimental therapeutics.

[36]  K. Yagi,et al.  Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. , 1979, Analytical biochemistry.

[37]  C. Buhusi,et al.  MENTAL DISORDERS , 1969 .

[38]  J. González‐Gallego,et al.  Quercetin Attenuates Nuclear Factor- (cid:1) B Activation and Nitric Oxide Production in Interleukin-1 (cid:2) –Activated Rat Hepatocytes 1 , 2005 .

[39]  R. Colman,et al.  Experimental models of inflammatory bowel disease. , 2003, Archivum immunologiae et therapiae experimentalis.

[40]  R. Schwabe,et al.  Role of glycogen synthase kinase-3 in TNF-alpha-induced NF-kappaB activation and apoptosis in hepatocytes. , 2002, American journal of physiology. Gastrointestinal and liver physiology.

[41]  S. Targan,et al.  Role of cytokines in the pathogenesis of inflammatory bowel disease. , 2000, Annual review of medicine.

[42]  Y. Naito,et al.  A novel water-soluble vitamin E derivative protects against experimental colitis in rats. , 1999, Antioxidants & redox signaling.

[43]  R. Ebstein,et al.  Effect of lithium on the physostigmine-induced behavioral syndrome and plasma cyclic GMP. , 1979, Journal of psychiatric research.

[44]  C. Pfeiffer,et al.  Experimental production of diffuse colitis in rats. , 1978, Digestion.